Aug 2026· Medical Science· Vol 14, pp. 494· 0 citations· 28 references
Medicine
TL;DR
SPCs were frequent in this hospital cohort and predominantly cutaneous, and older age was an independent predictor, while actinic keratosis was a strong unadjusted marker.
Abstract
Background and objectives: Melanoma survivors may develop additional primary malignancies, but data from Eastern European hospital cohorts are scarce. We aimed to estimate the observed incidence of second primary cancers (SPCs) within a Romanian referral-centre cohort, identify associated factors, and explore the association of SPC occurrence with overall survival. Methods: We conducted a retrospective, hospital-based cohort study of 394 patients with histopathologically confirmed cutaneous melanoma followed at two referral centres in Cluj-Napoca. Additional malignancies were counted as new primaries only when clinical and/or histopathological documentation distinguished them from recurrence or metastasis. Incidence density was expressed per 1000 person-years. Multivariable logistic regression assessed age, sex, residence, and Breslow thickness. Fixed-covariate Cox and Kaplan–Meier analyses were considered exploratory because of immortal-time and competing-risk limitations. Results: Over 1848 person-years, 79 patients (20.1%) developed at least one SPC (131 events; observed incidence 70.9/1000 person-years), most frequently cutaneous (53.6/1000 person-years). SPC occurrence increased with age (Cochran–Armitage Z = 5.63, p < 0.001); the Kaplan–Meier complement estimate reached 20.7% at five years. Age independently predicted SPC (OR 1.86 per decade, p < 0.001), whereas greater Breslow thickness was inversely associated (OR 0.86, p = 0.008). Actinic keratosis showed a strong unadjusted association (OR 6.64, p < 0.001) but was not included in the adjusted model. The fixed-status Cox model showed lower mortality among patients with an SPC (HR 0.36, p < 0.001), a finding vulnerable to detection and immortal-time bias. Conclusions: SPCs were frequent in this hospital cohort and predominantly cutaneous. Older age was an independent predictor, while actinic keratosis was a strong unadjusted marker. Prospective, population-based validation is needed before surveillance intensity is individualised.
Background The presence of prior malignancies at the time of cutaneous malignant melanoma diagnosis may be a critical determinant of patient survival. The present study evaluated the clinical and economic impact of prevalent cancers at the time of cutaneous melanoma diagnosis. Methods This population-based retrospectiv...
Alessandra Buja, S. Guzzinati, Chiara Trevisiol et al.· Frontiers in Oncology· 0 citations
BACKGROUND
Melanoma in young adults causes substantial years of life lost because deaths occur early. Detection pathways, reasons for consultation, and sex differences may influence tumor thickness and prognosis, but evidence in this age group remains limited.
METHODS
We conducted a retrospective cohort study of pati...
B. Rodríguez-Sánchez, J. Avilés-Izquierdo, Jorge Martín-Nieto-González et al.· International Journal of Der...· 1 citation
BACKGROUND
Patients with rare cancers have consistently been reported to have poorer survival than patients with common cancers. We hypothesized that the excess mortality could be attributable to differences in tumor histology and stage at diagnosis and, explored whether it reflected a broader relationship between canc...
S. M. Kønig, S. Friis, T. Kjær et al.· Journal of the National Canc...· 0 citations
In competing-risk analyses, Black race, and basaloid histology were independently associated with increased SPC risk, while advanced stage and absence of surgery were associated with lower observed incidence, likely reflecting competing mortality.
H. Tran, Frank Z. Jing, D. L. Van et al.· Urologic oncology· 0 citations
Background and Objectives: Basal cell carcinoma (BCC) is the most common non-melanoma skin cancer, and its global incidence rate constantly rises. However, there are no current epidemiological data for many regions, including Małopolska in southern Poland. This study aimed to characterize the clinical and histological...
Eliza Siemaszko-Oniszczuk, Przemysław Hałubiec, A. Wojas-Pelc et al.· Medicina· 0 citations
The key to improving outcomes in this growing subset of oncology patients lies in early identification by vigilant follow-up, appropriate screening, and management strategies tailored to the individual patient.
S. Swain, Lalatendu Moharana, Sudam Sadangi et al.· South Asian Journal of Cance...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.